Daniel J. Burdick
ORCID：0000-0003-3475-7397
发表论文 44 篇 · 总被引 2298 次 · h-index 24
代表论文
- Ser 1292 Autophosphorylation Is an Indicator of LRRK2 Kinase Activity and Contributes to the Cellular Effects of PD Mutations (2012 · Science Translational Medicine · 被引 378)
- Discovery of Highly Potent, Selective, and Brain-Penetrable Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors (2012 · Journal of Medicinal Chemistry · 被引 165)
- Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial (2023 · The Lancet Neurology · 被引 137)
- Discovery of Highly Potent, Selective, and Brain-Penetrant Aminopyrazole Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors (2013 · Journal of Medicinal Chemistry · 被引 126)
- Diving into the Water: Inducible Binding Conformations for BRD4, TAF1(2), BRD9, and CECR2 Bromodomains (2016 · Journal of Medicinal Chemistry · 被引 119)
- Discovery of a cryptic peptide-binding site on PCSK9 and design of antagonists (2017 · Nature Structural & Molecular Biology · 被引 67)